Shifts in the prevalence of etiological agents associated with bacterial sepsis in neonates have been historically documented. The predominance of beta-hemolytic streptococci, the overwhelming majority of which belong to Lancefield group A, observed in the 1930s and 1940s had disappeared until the 1970s when Lancefield group B became the single most frequently observed pathogen in many U.S. hospitals. During the past few years, several reports have indicated that other streptococci, in particular, both group D (1, 2, 5, 10, 12) and non-group D (4, 11, 14) alpha-hemolytic strains, may occasionally cause sepsis or meningitis in neonates.
We have recently reported a striking increase, at a Houston hospital with ca. 14,000 deliveries annually, of neonatal sepsis attributable to nongroup D alpha-hemolytic streptococci (4 (11, 14) in neonates. In our hospital, non-group D alpha-hemolytic streptococci have been isolated frequently since 1978 from the blood cultures of neonates with signs of sepsis. The reason(s) for the increasing prevalence of such neonatal isolates remains unknown, but information regarding the particular species isolated might provide some insight into the virulence of certain strains, especially if the species distribution is compared with that of maternal genital isolates.
Although there is little information pertaining to the species distribution of alpha-hemolytic streptococci isolated from genital cultures of women, Facklam (8) reported that S. mitis was found in 11.5% of cultures from gynecology patients, a prevalence consistent with that reported here (3.4%). The species distribution of neonatal blood culture isolates has not been done previously, but Ruoff and Kunz (15) The heterogeneity of organisms designated as viridans streptococci has made their classification difficult. Species identification has been attempted previously by serological (6) and physiological (8) methods as well as those which define cell wall components (6) or the presence of a chromophore (3). Some investigators have used bacteriocin fingerprinting techniques (7). Serological methods have failed to provide sufficient accuracy (6, 8) , and methods which determine the presence or absence of rhamnose and ribitol teichoic acid (6) are impractical for clinical laboratories. In this country, the most widely used and practical scheme is that described by Facklam (8) . On the basis of physiological requirements, he suggested 10 species: S. mutans, S. salivarius, S. uberis, S. sanguis I, S. sanguis II, S. MG-intermedius, S. mitis, S. anginosusconstellatus, S. morbillorum, and S. acidominimus.
Employing the Facklam scheme, we detected a significantly different species distribution of non-group D alpha-hemolytic streptococci isolated from maternal genital compared with that of neonatal blood culture isolates. However, if the species were determined by either the method of Colman and Williams (6) or chromophore detection (3), both S. mitis and S. sanguis II would be classified as S. mitior, and these differences would disappear. Both S. mitis and S. sanguis II are deficient in rhamnose and rich in ribitol teichoic acid and are the only species which produce a chromophore. Despite these differences in proposed species identification methods, we believe that the Facklam scheme is a useful tool for defining the epidemiology of human infection caused by non-group D alphahemolytic streptococci. It is our hope that additional studies on the species identification of clinically significant isolates, as well as those of normal flora, will increase our understanding of the epidemiology and pathogenesis of human infections associated with these organisms.
